{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:30:00Z","timestamp":1770741000722,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008789","name":"Department of Science & Technology","doi-asserted-by":"publisher","award":["SR\/FST\/LSI-453\/2010"],"award-info":[{"award-number":["SR\/FST\/LSI-453\/2010"]}],"id":[{"id":"10.13039\/501100008789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009536","name":"SASTRA Deemed University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009536","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.msec.2018.07.048","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T12:41:12Z","timestamp":1532090472000},"page":"875-891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Harnessing the pleiotropic effects of atorvastatin-fenofibrate combination for cardiovascular stents"],"prefix":"10.1016","volume":"92","author":[{"given":"Purandhi","family":"Roopmani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma Maheswari","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msec.2018.07.048_bb0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jacc.2005.08.057","article-title":"Are drug-eluting stents the preferred treatment for multivessel coronary artery disease?","volume":"47","author":"Klein","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.msec.2018.07.048_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/vhrm.2008.04.01.31","article-title":"Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)","volume":"4","author":"Sheiban","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.msec.2018.07.048_bb0015","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1021\/acs.bioconjchem.5b00192","article-title":"Polymer-free drug-eluting stents: an overview of coating strategies and comparison with polymer-coated drug-eluting stents","volume":"26","author":"Chen","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.msec.2018.07.048_bb0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCINTERVENTIONS.110.959882","article-title":"Delineating the numerous causes of drug-eluting stent restenosis","volume":"4","author":"Farooq","year":"2011","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.msec.2018.07.048_bb0025","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gr\u00fcntzig Lecture ESC","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.msec.2018.07.048_bb0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.104.508937","article-title":"Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents","volume":"112","author":"Finn","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.msec.2018.07.048_bb0035","doi-asserted-by":"crossref","first-page":"291871","DOI":"10.1155\/2015\/291871","article-title":"Accelerated recovery of endothelium function after stent implantation with the use of a novel systemic nanoparticle curcumin","volume":"2015","author":"Lu","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.msec.2018.07.048_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138459","article-title":"Stents eluting 6-mercaptopurine reduce neointima formation and inflammation while enhancing strut coverage in rabbits","volume":"10","author":"Ruiter","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.msec.2018.07.048_bb0045","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1021\/am405124z","article-title":"Gallic acid tailoring surface functionalities of plasma-polymerized allylamine-coated 316L SS to selectively direct vascular endothelial and smooth muscle cell fate for enhanced endothelialization","volume":"6","author":"Yang","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.msec.2018.07.048_bb0050","doi-asserted-by":"crossref","first-page":"14608","DOI":"10.1021\/am503925r","article-title":"Mussel-inspired one-step adherent coating rich in amine groups for covalent immobilization of heparin: hemocompatibility, growth behaviors of vascular cells, and tissue response","volume":"6","author":"Yang","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.msec.2018.07.048_bb0055","first-page":"109","article-title":"Endovascular gene delivery from a stent platform: gene-eluting stents","volume":"1","author":"Fishbein","year":"2013","journal-title":"Angiol. Open Access"},{"key":"10.1016\/j.msec.2018.07.048_bb0060","article-title":"Anti-CD133 antibody immobilized on the surface of stents enhances endothelialization","volume":"2014","author":"Li","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.msec.2018.07.048_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2012.03.019","article-title":"Dual drug-eluting stent","volume":"159","author":"Park","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2018.07.048_bb0070","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/eurheartj\/ehp044","article-title":"A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents","volume":"30","author":"Byrne","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.msec.2018.07.048_bb0075","doi-asserted-by":"crossref","first-page":"12944","DOI":"10.1021\/am403615q","article-title":"Dual drug-eluting stents coated with multilayers of hydrophobic heparin and Sirolimus","volume":"5","author":"Su","year":"2013","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.msec.2018.07.048_bb0080","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.biomaterials.2010.01.147","article-title":"In vitro and in vivo performance of a Dual Drug-Eluting Stent (DDES)","volume":"31","author":"Huang","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.msec.2018.07.048_bb0085","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MOL.0b013e328332e9ef","article-title":"Combination therapy of statins and fibrates in the management of cardiovascular risk","volume":"20","author":"Fi\u00e9vet","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.msec.2018.07.048_bb0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: mechanism of action and effects","volume":"5","author":"Stancu","year":"2001","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.msec.2018.07.048_bb0095","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/cvr\/cvt152","article-title":"Effects of peroxisome proliferator-activated receptor-\u03b2 activation in endothelin-dependent hypertension","volume":"99","author":"Zarzuelo","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.msec.2018.07.048_bb0100","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1067\/mhj.2002.124833","article-title":"Comparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemia","volume":"44","author":"Melenovsky","year":"2002","journal-title":"Am. Heart J."},{"key":"10.1016\/j.msec.2018.07.048_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3863726","article-title":"Modulation of hypercholesterolemia-induced oxidative\/nitrative stress in the heart","volume":"2016","author":"Csonka","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.msec.2018.07.048_bb0110","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jacc.2005.02.052","article-title":"Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia","volume":"45","author":"Koh","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.msec.2018.07.048_bb0115","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/ATVBAHA.108.170530","article-title":"Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome","volume":"28","author":"Chan","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.msec.2018.07.048_bb0120","series-title":"Beneficial Vascular and Metabolic Effects of Peroxisome Proliferator\u2013Activated Receptor-activators Hypertension","first-page":"1086","volume":"46","author":"Han","year":"2005"},{"key":"10.1016\/j.msec.2018.07.048_bb0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0008-6363(01)00382-0","article-title":"Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial \u2014 FAT)","volume":"52","author":"Malik","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.msec.2018.07.048_bb0130","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/eurheartj\/ehp556","article-title":"Statins, fibrates, and venous thromboembolism: a meta-analysis","volume":"31","author":"Squizzato","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.msec.2018.07.048_bb0135","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/HYPERTENSIONAHA.112.203661","article-title":"Fenofibrate improves vascular endothelial function by reducing oxidative stress while increasing eNOS in healthy normolipidemic older adults","volume":"60","author":"Walker","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.msec.2018.07.048_bb0140","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2174\/138161212799504803","article-title":"Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials","volume":"18","author":"Antonopoulos","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.msec.2018.07.048_bb0145","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1476-5381.2009.00350.x","article-title":"Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha","volume":"158","author":"Huang","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.msec.2018.07.048_bb0150","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s13233-016-4130-5","article-title":"Development of a novel dual PLGA and alginate coated drug-eluting stent for enhanced blood compatibility","volume":"24","author":"Kim","year":"2016","journal-title":"Macromol. Res."},{"key":"10.1016\/j.msec.2018.07.048_bb0155","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3390\/ijms17091490","article-title":"The ultimaster biodegradable-polymer sirolimus-eluting stent: an updated review of clinical evidence","volume":"17","author":"Chisari","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msec.2018.07.048_bb0160","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.apsusc.2013.03.137","article-title":"Preparation of enhanced hydrophobic poly(l-lactide-co-\u03b5-caprolactone) films surface and its blood compatibility","volume":"276","author":"Kim","year":"2013","journal-title":"Appl. Surf. Sci."},{"key":"10.1016\/j.msec.2018.07.048_bb0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jmbbm.2015.04.007","article-title":"Supramolecular structure, phase behavior and thermo-rheological properties of a poly(l-lactide-co-\u03b5-caprolactone) statistical copolymer","volume":"48","author":"Ugartemendiaa","year":"2015","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.msec.2018.07.048_bb0170","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jss.2005.05.016","article-title":"The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells","volume":"129","author":"Corpataux","year":"2005","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.msec.2018.07.048_bb0175","first-page":"671","article-title":"Involvement of endothelial PECAM-1\/CD31 in angiogenesis","volume":"151","author":"DeLisser","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.msec.2018.07.048_bb0180","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1073\/pnas.0802857105","article-title":"Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.msec.2018.07.048_bb0185","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3390\/nu5062231","article-title":"The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses","volume":"5","author":"Soliman","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.msec.2018.07.048_bb0190","first-page":"1043","article-title":"Inhibition of autophagy increases proliferation inhibition and apoptosis induced by the PI3K\/mTOR inhibitor NVP-BEZ235 in breast cancer cells","volume":"61","author":"Ji","year":"2015","journal-title":"Clin. Lab."},{"key":"10.1016\/j.msec.2018.07.048_bb0195","first-page":"4188","article-title":"Evidence for anti-inflammatory activity of statins and PPAR\u03b1 activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro blood","volume":"103","author":"Kleemann","year":"2004"},{"key":"10.1016\/j.msec.2018.07.048_bb0200","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/BSR20090048","article-title":"Induction of inducible nitric oxide synthase increases the production of reactive oxygen species in RAW264.7 macrophages","volume":"30","author":"Zhao","year":"2010","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.msec.2018.07.048_bb0205","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."}],"updated-by":[{"DOI":"10.1016\/j.msec.2019.03.067","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000}}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092849311734064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092849311734064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:33:27Z","timestamp":1760531607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092849311734064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":41,"alternative-id":["S092849311734064X"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2018.07.048","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.msec.2019.03.067","asserted-by":"object"}]},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing the pleiotropic effects of atorvastatin-fenofibrate combination for cardiovascular stents","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2018.07.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}